Cardioprotective Properties of OMT-28
Kranrod et al. JBC 2024
VISIT
Pulmonary Hypertension: Omega-3 epoxyeicosanoids reduce development of PH
Moriyama et al. Nature Comm 2022
VISIT
Endotoxemia: Amerlioration of endotoxemia by a synthetic analog of omega-3 epoxyeicosanoids
Shikuma et al. Front Immunol 2022
VISIT
Heart Failure: Mitochondrial Dysfunction and Inflammaging in Heart Failure: Novel Roles of CYP-Derived Epoxylipids
Keshavarz-Bahaghighat et al. Cells 2020
VISIT
Atrial Fibrillation: Assessment of OMT-28, a synthetic analog of omega-3 epoxyeicosanoids, in patients with persistent atrial fibrillation: Rationale and design of the PROMISE-AF phase II study
Berlin et al. Int J Cardiol Heart Vasc 2020
VISIT
Review: Therapeutic potential of omega-3 fatty acid-derived epoxyeicosanoids in cardiovascular and inflammatory diseases
Schunck et al. Pharmacol Ther 2018
VISIT
Chorideal Neovascularization: 17,18-EEQ and stable synthetic analog C21 reduce chorideal neovascularization via a immunomodulatory mechanism of action
Hasegawa et al. PNAS 2017
VISIT
Chorideal Neovascularization: 17,18-EEQ as active EPA metabolite, mediating reduction of chorideal neovascularization
Yanai et al. PNAS 2013
VISIT
